経口ネフォパムの術後鎮痛効果 (NefPO)
高位脛骨骨切り術後のネフォパム経口投与の術後鎮痛効果 : 無作為対照試験
Primary knee arthroplasty by total prosthesis is a painful surgery, performed on patients with advanced gonarthrosis (stage III), thus already presenting hyperalgesia and hyperalgesia and allodynia. This terrain makes the risk of postoperative hyperalgesia but also of persistent postoperative risk of persistent post-surgical pain.
Nefopam is a non-opioid centrally acting analgesic drug used as a part of multimodal analgesia. The opioid-sparing effect of nefopam is still controversial across various surgical procedures. In France nefopam is only available as a parenteral formulation; however it is often administered orally. There is currently no study addressing the efficacy of oral nefopam for the postoperative pain management including pain prevention.
The investigators conduct a prospective, double-blinded randomized controlled study with the main objective to examine the effect of perioperative orally administered nefopam on postoperative pain after a total knee arthroplasty. Secondary objectives include the quantification of wound allodynia, analysis of adverse events, clinical outcomes, and a pharmacokinetic study of orally given nefopam (plasma and cerebrospinal fluid dosage).
調査の概要
研究の種類
入学 (実際)
段階
- フェーズ2
連絡先と場所
研究場所
-
-
-
Lyon、フランス、69004
- Département d'Anesthésie Réanimation, Groupement Hospitalier Nord, Hospices Civils de Lyon
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- adult patients scheduled for a total knee arthroplasty under spinal anesthesia at the Hopital de la Croix Rousse, Hospice Civils de Lyon, France.
- ASA (American Society of Anesthesiology) class between 1 et 3.
- written informed consent
Exclusion Criteria:
- any contraindication for nefopam (known hypersensitivity, past medical history of seizures, urinary retention, benign prostate hyperplasia, angle glaucoma, ischemic cardiomyopathy waiting for revascularization, atrial fibrillation)
- medical conditions known to influence the pharmacokinetics of nefopam (chronic kidney failure with Glomerular Filtration Rate (GFR) <30mL/min/1,73m2, liver failure, current treatment with rifampicin, carbamazepine, azoles fungicides, macrolides)
- current treatment with benzodiazepines, anxiolytics, antidepressants, histamine H1 antagonists, neuroleptics, baclofen, thalidomide, barbiturates
- medical history of gastric or esophageal surgery.
- phenylketonuria
- pregnancy or breastfeeding
- past use of oral nefopam
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:NEFOPAM 60mg PO/ 8 hours
Oral administration of nefopam 60mg 2 hours before the surgery following by 60mg each 8h for 24h. |
Oral administration of nefopam 60mg 2 hours before the surgery following by 60mg each 8h for 24h. Oral nefopam is prepared ex-tempore from the intravenous formulation adding a taste masking compound by a non-caring nurse following detailed instructions. |
|
プラセボコンパレーター:Placebo
Oral administration of a placebo 2 hours before the surgery following by one administration each 8h for 24h. |
Oral administration of a placebo 2 hours before the surgery following by one administration each 8h for 24h. Oral placebo is prepared ex-tempore with a taste masking compound by a non-charge nurse following detailed instructions |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Total morphine consumption within 24h after the surgery.
時間枠:24 hours after the surgery.
|
Total dose of morphine consumed in 24h frame by a patient (PCA and/or additional morphine administration - parenteral or oral) |
24 hours after the surgery.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Hyperalgesia - Pressure Pain Threshold
時間枠:24 hours after the surgery
|
The pressure pain threshold is determined using a Von Frey monofilaments on both (operated and contralateral) knees 24 hours after incision. |
24 hours after the surgery
|
|
Hyperalgesia - Punctate Pain Intensity
時間枠:24 hours after the surgery
|
The Punctuate pain intensity is determined using a Von Frey monofilament n°5,88 (60 g/mm2) and a pain scale (0 = no pain, 10 = the worst pain), on both the operated knee and the contralateral knee 24 hours after incision. |
24 hours after the surgery
|
|
Hyperalgesia - Allodynia zone
時間枠:24 hours after the surgery
|
The extension of allodynia around the wound is measured using a calibrated brush (100 mNewton) 24 hours after incision. |
24 hours after the surgery
|
|
Pain intensity
時間枠:24 hours after the surgery and 3 months after the surgery
|
Self-reported pain intensity at rest and while moving the operated leg. Each item is scored on a scale ranging from 0 to 10 (0 = no pain, 10 = the worst pain) |
24 hours after the surgery and 3 months after the surgery
|
|
Self reported safety outcomes
時間枠:24 hours after the surgery
|
Nausea and vomiting, unusual sweating, drowsiness, hallucinations, nightmares, palpitations, irritability |
24 hours after the surgery
|
|
Measures Safety outcomes
時間枠:24 hours after the surgery
|
The incidence of acute urinary retention, and mean cardiac frequency (calculated from the recorded cardiac frequency 3 times a day) are recorded, confusion, acute angle glaucoma. |
24 hours after the surgery
|
|
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam
時間枠:2 hours after the first oral administration of nefopam or Placebo.
|
Plasmatic and cerebrospinal fluid concentration of nefopam is measured. |
2 hours after the first oral administration of nefopam or Placebo.
|
|
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-beta-D-glucuronide
時間枠:2 hours after the first oral administration of nefopam or Placebo.
|
Plasmatic and cerebrospinal fluid concentration of nefopam-beta-D-glucuronide is measured. |
2 hours after the first oral administration of nefopam or Placebo.
|
|
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-N-oxyde
時間枠:2 hours after the first oral administration of nefopam or Placebo.
|
Plasmatic and cerebrospinal fluid concentration of nefopam-N-oxyde is measured. |
2 hours after the first oral administration of nefopam or Placebo.
|
|
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of nefopam-N-demethyl
時間枠:2 hours after the first oral administration of nefopam or Placebo.
|
Plasmatic and cerebrospinal fluid concentration of nefopam-N-demethyl is measured. |
2 hours after the first oral administration of nefopam or Placebo.
|
|
Pharmacokinetics:Plasmatic and cerebrospinal fluid concentration of Nefopam hydrochloride
時間枠:2 hours after the first oral administration of nefopam or Placebo.
|
Plasmatic and cerebrospinal fluid concentration of Nefopam hydrochloride is measured. |
2 hours after the first oral administration of nefopam or Placebo.
|
|
Persistent postoperative pain - DN4 (or DN2 by phone)
時間枠:3 months after the surgery
|
The DN4 questionnaire (or DN2 questionnaire if the visit is realized by phone) ("Douleurs Neuropathiques 4/2" = Neuropathic pain 4/2 in french) is recorded to investigate persistent postoperative pain defined as pain on the operated knee 3 months after the surgery. |
3 months after the surgery
|
|
Persistent postoperative pain - DN4
時間枠:4 months after the surgery
|
The DN2 questionnaire ("Douleurs Neuropathiques 2" = Neuropathic pain 2 in french, abbreviated DN4 questionnaire) is recorded by phone if the 3 months visit is realized out of time. If the score is positive (>=3), the DN4 is recorded at hospital within 2 weeks post the 3 months visit. |
4 months after the surgery
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Frederic AUBRUN, MD/PHD、Département d'Anesthésie Réanimation, Hopital de la Croix Rousse
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。